Dataset Information


Glycosylation Alterations in Multiple Sclerosis Show Increased Proinflammatory Potential.

ABSTRACT: Multiple sclerosis (MS) is an inflammatory autoimmune disorder affecting the central nervous system (CNS), with unresolved aetiology. Previous studies have implicated N-glycosylation, a highly regulated enzymatic attachment of complex sugars to targeted proteins, in MS pathogenesis. We investigated individual variation in N-glycosylation of the total plasma proteome and of IgG in MS. Both plasma protein and IgG N-glycans were chromatographically profiled and quantified in 83 MS cases and 88 age- and sex-matched controls. Comparing levels of glycosylation features between MS cases and controls revealed that core fucosylation (p = 6.96 × 10-3) and abundance of high-mannose structures (p = 1.48 × 10-2) were the most prominently altered IgG glycosylation traits. Significant changes in plasma protein N-glycome composition were observed for antennary fucosylated, tri- and tetrasialylated, tri- and tetragalactosylated, high-branched N-glycans (p-value range 1.66 × 10-2-4.28 × 10-2). Classification performance of N-glycans was examined by ROC curve analysis, resulting in an AUC of 0.852 for the total plasma N-glycome and 0.798 for IgG N-glycome prediction models. Our results indicate that multiple aspects of protein glycosylation are altered in MS, showing increased proinflammatory potential. N-glycan alterations showed substantial value in classification of the disease status, nonetheless, additional studies are warranted to explore their exact role in MS development and utility as biomarkers.

PROVIDER: S-EPMC7599553 | BioStudies |

REPOSITORIES: biostudies

Similar Datasets

| S-EPMC3430715 | BioStudies
| S-EPMC6249776 | BioStudies
| S-EPMC6077116 | BioStudies
| S-EPMC7059190 | BioStudies
| S-EPMC3335910 | BioStudies
| S-EPMC7304067 | BioStudies
| S-EPMC8347577 | BioStudies
| S-EPMC8074232 | BioStudies
| S-EPMC2688389 | BioStudies
| S-EPMC5528923 | BioStudies